As of 2026-10-03, the Relative Valuation of Entheon Biomedical Corp (ENBI.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.06 CAD, the upside of Entheon Biomedical Corp based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2026-09-28 | -3.59 |
| 2026-09-22 | -2.99 |
| 2026-09-15 | -2.09 |
| 2026-09-10 | -3.59 |
| 2026-09-02 | -3.59 |
| 2026-07-24 | -3.59 |
| 2026-07-21 | -3.59 |
| 2026-07-14 | -4.18 |
| 2026-07-09 | -3.88 |
| 2026-07-07 | -3.59 |